Today on in-pharmatechnologist.com
 
More pharmas implicated in Iraq bribery probe

Merck divests API plant; hands out large contract

A drug cocktail to bust brain tumours

Pharmaceutical manufacturing: people on the move

New company formed for drug delivery tech

 
   
Related Industry News
 
New drug target leaves lung cancer cells alone, lonely and dying

Quintiles in $3bn investment deal

Small molecules still leading the way into the clinic

Two dimensions are better than one when profiling metabolites

 
 

Pharmaceutical & technology

In association with
PharmaPack
Breaking News on Pharmaceutical Technology
Daily  Wednesday 02 January 2008 Forward to a colleague

Access Full Stories



More pharmas implicated in Iraq bribery probe
While GSK, AstraZeneca and Eli Lilly have hit the headlines in the UK Serious Fraud Office's (SFO) investigation into illegal bribes paid to Saddam Hussein's Iraqi regime, many more pharma firms are on the organisation's... Read


Merck divests API plant; hands out large contract
Merck & Co has handed the reins of one of its US active pharmaceutical ingredient (API) manufacturing facilities over to new a owner, who has also secured a lucrative contract manufacturing deal with the drug... Read


A drug cocktail to bust brain tumours
A team of US researchers have uncovered a cocktail of three drugs that could be effective at treating every patient with a particular type of brain cancer that typically has a dismal prognosis... Read


Pharmaceutical manufacturing: people on the move
Applied Biosystems, Pharmos, Pearl Therapeutics, Pacira Pharmaceuticals and Covance have all had people on the move in the world of pharmaceutical manufacturing... Read


New company formed for drug delivery tech
Jerusalem-based Yissum has formed a spin-off company Nanolymf, which will be dedicated to advancing a nanotechnology controlled-release drug delivery platform... Read


All News Headlines for:
January | December | November

Related Industry News



New drug target leaves lung cancer cells alone, lonely and dying
It seems even tumour cells can get lonely; scientists have discovered that by cutting off a key gene, lung cancer tumour cells are left 'homeless' and they can't survive on their own... Read


Quintiles in $3bn investment deal
One Equity Partners (OEP), the private equity arm of JPMorgan Chase, is in the process of selling its stake in Quintiles for a reported sum of over $3bn... Read


Small molecules still leading the way into the clinic
DrugResearcher.com brings you its annual round up of all the drugs that entered clinical development in 2007... Read


Two dimensions are better than one when profiling metabolites
US researchers have shown that 2D NMR (nuclear magnetic resonance) experiments can greatly enhance the ability of metabolic profiling to quantify disease identification and progression... Read

Annual round up of all drugs entering Phase I

Small molecules still leading the way into the clinic

DrugResearcher.com brings you its annual round up of all the drugs that entered clinical development in 2007. Read



Previous Headlines



FMC expands excipient production
FMC BioPolymer is to expand its microcrystalline cellulose (MCC) production in a bid to meet demand for the company's excipients... Read


Pharmaceutical manufacturing: news in brief
In-PharmaTechnologist.com brings you a selection of recent headlines from around the pharmaceutical manufacturing industry... Read


Keata buys Pfizer's Canadian facility
PharmEng's subsidiary Keata Pharma is the new owner of Pfizer's manufacturing facility in Arnprior, Canada, which the drug giant has been trying to pass on for over a year... Read


Consort Medical feeling the loss of Exubera
Consort Medical's UK operations may be in line for more job losses as further collateral damage from Pfizer's withdrawal of Exubera from the market... Read


Flamel tech used for Merck Serono drug
France-based Flamel Technologies and Merck Serono have shook hands on a new €2m ($2.9m) deal which would see Flamel's Medusa technology used to develop an extended-release profile of an undisclosed therapeutic... Read

Technical / White Papers, Case studies, Web casts
Shop floor integration at Novartis Singapore - Case Study

Manufacturing Execution Systems to Optimize the Pharmaceutical Supply Chain - Technical / White Paper



Product Information - brochures, Web centers
Transdermal Sufentanil Licensing Opportunity - Application Notes

Reproducible, homogeneous dry dispersions by the Morphologi® - Application Notes

A Review of Dissolution tests with the Flow Through Method - Application Notes



Product Innovation Alerts - Free of Charge
Indicate your research interests and receive alerts on relevant products and market innovations
Cleanroom, safety equipment, supplies
Contract services (outsourcing)
Drug delivery systems
Ingredients, excipients and raw materials
IT solutions
Lab equipment & consumables
Packaging machinery & supplies
Processing (automation, control, separation...)
QA/QC & validation
Tabletting, coating & ancillary equipment




Free Newsletters for Pharmaceuticals
Access now !Choose from over 20 industry e-newsletters
Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here

Forward to a colleague

To continue to receive this newsletter in your inbox, please add
newsletter@In-PharmaTechnologist.com to your address book

Update preferences | Change your email address | Unsubscribe

Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback

© 2008 - Decision News Media S.A.S - All Rights Reserved
Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France
http://www.decisionnewsmedia.com